Skip to main content
Erschienen in: Infection 4/2014

01.08.2014 | Clinical and Epidemiological Study

Predictive factors of bacteremia in patients with febrile urinary tract infection: an experience at a tertiary care center

verfasst von: H. Lee, Y.-S. Lee, R. Jeong, Y.-J. Kim, S. Ahn

Erschienen in: Infection | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the clinical features in adult patients with febrile urinary tract infection (UTI) who visited the emergency department (ED) and to determine the predictive factors of bacteremia among the initial presenting clinical features.

Methods

This retrospective cohort study was conducted at the ED of a tertiary hospital in Korea from 1 January 2012 to 31 December 2012. All adult patients who were diagnosed with febrile UTI and for whom data on blood and urine cultures were available were included in the study. Clinical examinations and laboratory tests were performed at the initial presentation.

Results

A total of the 325 patients with febrile UTI (median age: 60 years) were included for analysis, of whom 82 % were female. Bacteremia was detected in 106 of the 325 patients (32.6 %), with Escherichia coli the most frequent pathogen detected (59.7 % of cases). Between the bacteremic and non-bacteremic groups, there was significant difference in age (67 vs. 57 years, respectively), flank pain (16 vs. 7.8 %), suprapubic discomfort (0 vs. 4.6 %), body temperature (38.8 vs. 38.3 °C), respiratory rate (21 vs. 20/min), platelet count (170 vs. 186 × 103/μL), C-reactive protein (10.2 vs. 8.3 mg/dL), and procalcitonin (1.5 vs. 0.3 ng/mL) (P < 0.05 for all). In the multivariate logistic regression analysis, age [odds ratio (OR) 1.03; 95 % confidence interval (CI) 1.01–1.05], systolic blood pressure of <90 mmHg (OR 3.27; 95 % CI 1.13–9.45), body temperature of >39 °C (OR 4.26; 95 % CI 2.28–7.96), and procalcitonin level of >0.5 ng/dL (OR 2.03; 95 % CI 1.07–3.86) were significantly associated with bacteremia.

Conclusion

Among our adult patients with febrile UTI, age, systolic blood pressure, body temperature, and procalcitonin were significantly associated with bacteremia. We therefore suggest that these factors should be considered when deciding upon treatment options for febrile UTI patients at the ED.
Literatur
1.
Zurück zum Zitat Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113[Suppl 1A]:5S–13S.PubMedCrossRef Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113[Suppl 1A]:5S–13S.PubMedCrossRef
2.
Zurück zum Zitat Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. 2011;13:1–38. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. 2011;13:1–38.
3.
Zurück zum Zitat Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551–81.PubMedCrossRef Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551–81.PubMedCrossRef
4.
Zurück zum Zitat Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328–34.PubMedCrossRef Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328–34.PubMedCrossRef
5.
Zurück zum Zitat Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103–20.PubMedCrossRef Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103–20.PubMedCrossRef
6.
Zurück zum Zitat Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med. 1997;15:148–51.PubMedCrossRef Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med. 1997;15:148–51.PubMedCrossRef
7.
Zurück zum Zitat Brown P, Ki M, Foxman B. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics. 2005;23:1123–42.PubMedCrossRef Brown P, Ki M, Foxman B. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics. 2005;23:1123–42.PubMedCrossRef
8.
Zurück zum Zitat Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol. 2003;13:144–50.PubMedCrossRef Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol. 2003;13:144–50.PubMedCrossRef
9.
Zurück zum Zitat Kim KS, Kim K, Jo YH, Kim TY, Lee JH, Lee SJ, et al. A simple model to predict bacteremia in women with acute pyelonephritis. J Infect. 2011;63:124–30.PubMedCrossRef Kim KS, Kim K, Jo YH, Kim TY, Lee JH, Lee SJ, et al. A simple model to predict bacteremia in women with acute pyelonephritis. J Infect. 2011;63:124–30.PubMedCrossRef
10.
Zurück zum Zitat Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures necessary in the management of women with complicated pyelonephritis? J Infect. 2006;53:235–40.PubMedCrossRef Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures necessary in the management of women with complicated pyelonephritis? J Infect. 2006;53:235–40.PubMedCrossRef
11.
Zurück zum Zitat Litke A, Bossart R, Regez K, Schild U, Guglielmetti M, Conca A, et al. The potential impact of biomarker-guided triage decisions for patients with urinary tract infections. Infection. 2013;41:799–809.PubMedCrossRef Litke A, Bossart R, Regez K, Schild U, Guglielmetti M, Conca A, et al. The potential impact of biomarker-guided triage decisions for patients with urinary tract infections. Infection. 2013;41:799–809.PubMedCrossRef
12.
Zurück zum Zitat van Nieuwkoop C, Hoppe BP, Bonten TN, Van’t Wout JW, Aarts NJ, Mertens BJ, et al. Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010;51:1266–72.PubMedCrossRef van Nieuwkoop C, Hoppe BP, Bonten TN, Van’t Wout JW, Aarts NJ, Mertens BJ, et al. Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010;51:1266–72.PubMedCrossRef
13.
Zurück zum Zitat Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect. 2005;50:296–305.PubMedCrossRef Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect. 2005;50:296–305.PubMedCrossRef
14.
Zurück zum Zitat Meyers BR, Sherman E, Mendelson MH, Velasquez G, Srulevitch-Chin E, Hubbard M, et al. Bloodstream infections in the elderly. Am J Med. 1989;86:379–84.PubMedCrossRef Meyers BR, Sherman E, Mendelson MH, Velasquez G, Srulevitch-Chin E, Hubbard M, et al. Bloodstream infections in the elderly. Am J Med. 1989;86:379–84.PubMedCrossRef
15.
Zurück zum Zitat Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49[Suppl 1]:S57–61.PubMed Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49[Suppl 1]:S57–61.PubMed
16.
Zurück zum Zitat Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605–8.PubMed Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605–8.PubMed
17.
Zurück zum Zitat Su CP, Chen TH, Chen SY, Ghiang WC, Wu GH, Sun HY, et al. Predictive model for bacteremia in adult patients with blood cultures performed at the emergency department: a preliminary report. J Microbiol Immunol Infect. 2011;44:449–55.PubMedCrossRef Su CP, Chen TH, Chen SY, Ghiang WC, Wu GH, Sun HY, et al. Predictive model for bacteremia in adult patients with blood cultures performed at the emergency department: a preliminary report. J Microbiol Immunol Infect. 2011;44:449–55.PubMedCrossRef
18.
Zurück zum Zitat Kim DY, Lee YS, Ahn S, Chun YH, Lim KS. The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Res Treat. 2011;43:176–80.PubMedCentralPubMedCrossRef Kim DY, Lee YS, Ahn S, Chun YH, Lim KS. The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Res Treat. 2011;43:176–80.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Muller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest. 2010;138:121–9.PubMedCrossRef Muller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest. 2010;138:121–9.PubMedCrossRef
20.
Zurück zum Zitat Kasem AJ, Bulloch B, Henry M, Shah K, Dalton H. Procalcitonin as a marker of bacteremia in children with fever and a central venous catheter presenting to the emergency department. Pediatr Emerg Care. 2012;28:1017–21.PubMedCrossRef Kasem AJ, Bulloch B, Henry M, Shah K, Dalton H. Procalcitonin as a marker of bacteremia in children with fever and a central venous catheter presenting to the emergency department. Pediatr Emerg Care. 2012;28:1017–21.PubMedCrossRef
21.
Zurück zum Zitat Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–17.PubMedCrossRef Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–17.PubMedCrossRef
22.
Zurück zum Zitat Ha YE, Kang CI, Wi YM, Chung DR, Kang ES, Lee NY, et al. Diagnostic usefulness of procalcitonin as a marker of bacteremia in patients with acute pyelonephritis. Scand J Clin Lab Invest. 2013;73:444–8.PubMedCrossRef Ha YE, Kang CI, Wi YM, Chung DR, Kang ES, Lee NY, et al. Diagnostic usefulness of procalcitonin as a marker of bacteremia in patients with acute pyelonephritis. Scand J Clin Lab Invest. 2013;73:444–8.PubMedCrossRef
23.
Zurück zum Zitat Shen CJ, Wu MS, Lin KH, Lin WL, Chen HC, Wu JY, et al. The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2013;32:807–14.PubMedCrossRef Shen CJ, Wu MS, Lin KH, Lin WL, Chen HC, Wu JY, et al. The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2013;32:807–14.PubMedCrossRef
24.
Zurück zum Zitat van Nieuwkoop C, Bonten TN, van’t Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010;14:R206.PubMedCentralPubMedCrossRef van Nieuwkoop C, Bonten TN, van’t Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010;14:R206.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med. 2007;50:34–41.PubMedCrossRef Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med. 2007;50:34–41.PubMedCrossRef
26.
Zurück zum Zitat Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–3.PubMedCrossRef Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–3.PubMedCrossRef
27.
Zurück zum Zitat Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med. 1992;1:281–7.PubMed Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med. 1992;1:281–7.PubMed
28.
Zurück zum Zitat Tolkoff-Rubin NE, Rubin RH. Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin North Am. 1997;11:707–17.PubMedCrossRef Tolkoff-Rubin NE, Rubin RH. Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin North Am. 1997;11:707–17.PubMedCrossRef
29.
Zurück zum Zitat Shigemura K, Tanaka K, Osawa K, Arakawa S, Miyake H, Fujisawa M. Clinical factors associated with shock in bacteremic UTI. Int Urol Nephrol. 2013;45:653–7.PubMedCrossRef Shigemura K, Tanaka K, Osawa K, Arakawa S, Miyake H, Fujisawa M. Clinical factors associated with shock in bacteremic UTI. Int Urol Nephrol. 2013;45:653–7.PubMedCrossRef
30.
Zurück zum Zitat Brown PD. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep. 2002;4:525–8.PubMedCrossRef Brown PD. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep. 2002;4:525–8.PubMedCrossRef
31.
Zurück zum Zitat Kung CH, Ku WW, Lee CH, Fung CP, Kuo SC, Chen TL, et al. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study. J Microbiol Immunol Infect. 2013. 10.1016/j.jmii.2013.08.006 Kung CH, Ku WW, Lee CH, Fung CP, Kuo SC, Chen TL, et al. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study. J Microbiol Immunol Infect. 2013. 10.​1016/​j.​jmii.​2013.​08.​006
32.
Zurück zum Zitat Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents. 2010;36:284–7.PubMedCrossRef Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents. 2010;36:284–7.PubMedCrossRef
33.
Zurück zum Zitat Park SH, Choi SM, Lee DG, Kim J, Choi JH, Kim SH, et al. Emergence of extended-spectrum beta-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. Microb Drug Resist. 2011;17:537–44.PubMedCrossRef Park SH, Choi SM, Lee DG, Kim J, Choi JH, Kim SH, et al. Emergence of extended-spectrum beta-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. Microb Drug Resist. 2011;17:537–44.PubMedCrossRef
34.
Zurück zum Zitat Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Cisneros JM, Pena C, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol. 2010;48:1726–31.PubMedCentralPubMedCrossRef Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Cisneros JM, Pena C, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol. 2010;48:1726–31.PubMedCentralPubMedCrossRef
Metadaten
Titel
Predictive factors of bacteremia in patients with febrile urinary tract infection: an experience at a tertiary care center
verfasst von
H. Lee
Y.-S. Lee
R. Jeong
Y.-J. Kim
S. Ahn
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 4/2014
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0615-3

Weitere Artikel der Ausgabe 4/2014

Infection 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.